Back to AI Radar

Sentinus.AI

Sentinus.AI 用虚拟 B 细胞筛选约 100 亿条抗体序列,预测亲和力、毒性和效力,再把候选送进湿实验确认。

Project analysis is shown in its source language.

Health & FitnessHealth & FitnessAnalyticsArtificial Intelligence
Visit website

Discovery source

First added in the .ai report on Oct 25, 2026

View report

Project insights

Value proposition
不依赖结构信息也能做从头设计,亲和力成熟在 42 个项目上报告 85.7% 成功率,湿实验命中率约 40%。
Problem solved
传统抗体筛选要数月湿实验,三维建模成本高,命中率通常只有几个百分点。
Pricing model
按项目收费,需预约演示;官网未公布单价
Target persona
肿瘤、代谢和传染病抗体项目,要在数小时内从百亿序列里选出亲和力和毒性候选
Business type
B2B

Screenshots

Sentinus.AI landing_page